Elevation Oncology, Inc. (ELEV)

NASDAQ: ELEV · IEX Real-Time Price · USD

2.640

-0.030 (-1.12%)

At close: Jul 19, 2024, 4:00 PM

2.550

-0.090 (-3.41%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Elevation Oncology Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Selling, General & Admin	14.42	14.9	15.83	8.45	1.8	0.54
Research & Development	24.15	25.43	78.72	23.6	15.48	5.34
Other Operating Expenses	0	5.11	0	0	0	0
Operating Expenses	38.57	45.45	94.55	32.05	17.28	5.88
Operating Income	-38.57	-45.45	-94.55	-32.05	-17.28	-5.88
Interest Expense / Income	-0.12	0	0	0	0	0
Other Expense / Income	0.86	0.23	0.51	-0.01	-0.01	-
Pretax Income	-39.32	-45.67	-95.06	-32.04	-17.27	-5.88
Income Tax	0.04	0.03	0.03	0	0	0
Net Income	-39.35	-45.7	-95.08	-32.04	-17.27	-5.88
Shares Outstanding (Basic)	47	34	23	12	1	1
Shares Outstanding (Diluted)	47	34	23	12	1	1
Shares Change	100.57%	46.46%	91.77%	1432.24%	6.43%	-
EPS (Basic)	-0.98	-1.34	-4.09	-2.64	-21.80	-7.91
EPS (Diluted)	-0.98	-1.34	-4.09	-2.64	-21.80	-7.91
Free Cash Flow	-48.92	-56.18	-85.57	-30.17	-12.37	-5.45
Free Cash Flow Per Share	-1.03	-1.65	-3.68	-2.49	-15.62	-7.33
EBITDA	-39.39	-45.64	-95.03	-32.02	-17.25	-5.88
Depreciation & Amortization	0.04	0.04	0.03	0.02	0.02	0
EBIT	-39.43	-45.67	-95.06	-32.04	-17.27	-5.88

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).